MESQUITE, Tx. (Dec. 16, 2025) — MPM Medical today announced a major expansion of its U.S. manufacturing capabilities with the acquisition of a full collagen manufacturing platform and the associated FDA 510(k) clearance for surgical collagen devices. This expansion significantly enhances MPM Medical’s ability to serve advanced wound care, surgical, and private-label partners with high-quality, American-made collagen products.

This announcement follows last week’s national press release introducing MPM Medical’s Collagen At-Home Wound Care Kits and Proprietary Wound Care Portal, reinforcing the company’s strategy to expand both its digital and manufacturing infrastructure in support of clinicians, health systems, and patients nationwide.

Beginning January 1, 2026, the company’s collagen production will operate out of MPM Medical’s 100,000 sq. ft. FDA-registered facility in Mesquite, Texas. The expansion includes advanced collagen processing technology, USP-grade compounding, and several high-capacity lyophilizers—dramatically increasing output for both branded products and growing private-label demand.

Expanded Collagen Portfolio

MPM Medical’s collagen portfolio now includes:

• MetaMatrix™ Antibacterial Surgical Collagen Powder
• ACM™ Surgical Collagen Pads
• TripleHelix™ Advanced Wound Care Collagen Powder, Pads, and Ropes
• At-Home Collagen Wound Care Kits

All collagen is U.S.-made, non-hydrolyzed, and derived from Type I bovine sources without added chemicals or chemical crosslinking—resulting in naturally low-endotoxin, low-pH, and highly biocompatible formulations suitable for surgical environments.

U.S.-Based Manufacturing Built for Scale

MPM Medical’s enhanced Mesquite, Texas manufacturing campus features:

• Class 8 cleanrooms
• Advanced lyophilizers
• FDA device-registration
• cGMP compliance
• Full microbiology and analytical testing labs
• Converting, packaging, sterilization, and regulatory support
• End-to-end private-label manufacturing solutions

“With supply chain instability and rising global manufacturing costs, the healthcare market is demanding trustworthy, U.S.-made collagen more than ever,” said Marissa Ransdell, MBA, WCSP, Director of Marketing at MPM Medical. “This expansion positions MPM Medical to meet that demand with higher quality control, reduced lead times, and unmatched flexibility for private-label partners.”

For full press release, click here.